Stock RXST RXSIGHT, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News RxSight, Inc.

Equities

RXST

US78349D1072

Real-time Estimate Cboe BZX
Other stock markets
 03:13:09 2024-06-10 pm EDT 		5-day change 1st Jan Change
58.84 USD +2.84% Intraday chart for RxSight, Inc. +4.46% +46.50%
May. 21 Rxsight Insider Bought Shares Worth $305,457, According to a Recent SEC Filing MT
May. 15 Transcript : RxSight, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 through May-16-2024

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
RxSight, Inc. To Participate in the Truist Securities Medtech Conference
GL
Rxsight Insider Bought Shares Worth $305,457, According to a Recent SEC Filing
MT
Transcript : RxSight, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 through May-16-2024
RxSight Raises $115 Million From Public Offering of Shares
MT
RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
GL
RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
AQ
RxSight, Inc. Announces Pricing of Public Offering of Common Stock
GL
RxSight, Inc. Announces Proposed Public Offering of Common Stock
GL
RxSight, Inc. Announces Proposed Public Offering of Common Stock
AQ
Wells Fargo Adjusts RxSight Price Target to $68 From $61, Maintains Overweight Rating
MT
Oppenheimer Adjusts RxSight Price Target to $72 From $61, Maintains Outperform Rating
MT
Needham Adjusts Price Target on RxSight to $75 From $64, Maintains Buy Rating
MT
BTIG Adjusts Price Target on RxSight to $72 From $61, Maintains Buy Rating
MT
RxSight Q1 Adjusted Loss Narrows, Revenue Rises
MT
Rxsight Insider Sold Shares Worth $2,405,872, According to a Recent SEC Filing
MT
Transcript : RxSight, Inc., Q1 2024 Earnings Call, May 06, 2024
Earnings Flash (RXST) RXSIGHT Posts Q1 Revenue $29.5M, vs. Street Est of $27.6M
MT
RxSight, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
RxSight, Inc. Reports First Quarter 2024 Financial Results
GL
RxSight, Inc. Reports First Quarter 2024 Financial Results
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RXST Stock
  4. News RxSight, Inc.